Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
36.12
+0.59 (1.66%)
Nov 20, 2024, 4:00 PM EST - Market closed
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $1.99 billion as of November 21, 2024. Its market cap has increased by 53.12% in one year.
Market Cap
1.99B
Enterprise Value
1.63B
1-Year Change
53.12%
Ranking
Category
Stock Price
$36.12
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $1.99B, an increase of 1,390.67%. That is a compound annual growth rate of 23.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.99B | 26.15% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Astrana Health | 1.99B |
| Mirum Pharmaceuticals | 1.99B |
| Evotec SE | 1.97B |
| Wave Life Sciences | 1.96B |
| GeneDx Holdings | 1.95B |
| NeoGenomics | 1.93B |
| Beam Therapeutics | 1.92B |
| National HealthCare | 1.91B |